Vienna, Austria – May 9th 2025 – Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its ...

Clients purchasing Biomay´s Cas9 will ... cell therapies. The CRISPR/Cas system, a transformative gene-editing technology, whose discovery was honored with the 2020 Nobel Prize in Chemistry ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

A U.S. company develops a trait that it says provides genetic resistance to sclerotinia, which can be challenging for growers ...

Casgevy (exagamglogene autotemcel or exa-cel) became the first drug based on the CRISPR/Cas9 gene-editing technology ... which earned its discoverers a Nobel Prize in 2020. The one-shot therapy ...

In October, CRISPR Therapeutics co-founder Emmanuelle Charpentier and Intellia co-founder Jennifer Doudna shared the 2020 Nobel Prize in Chemistry for their work on CRISP/Cas9. Companion ...

Doudna’s pioneering work in the development of CRISPR-Cas9 gene editing, in collaboration with Dr. Emmanuelle Charpentier, is widely regarded as one of the most significant discoveries in the history ...

“We have demonstrated, for the first time worldwide, that CRISPR-Cas9 can be used to incorporate a desired sequence into ...

George Mason University’s College of Humanities and Social Sciences released a report examining Nobel Prize winners in late 2024, and one of the findings has garnered interest, in light of the ...